600789 Stock Overview
Shandong Lukang Pharmaceutical Co.,Ltd. manufactures and sells bio-pharmaceuticals and antibiotics in China.
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 0/6 |
| Past Performance | 4/6 |
| Financial Health | 4/6 |
| Dividends | 3/6 |
Shandong Lukang Pharmaceutical Co.,Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥7.14 |
| 52 Week High | CN¥9.03 |
| 52 Week Low | CN¥5.04 |
| Beta | 0.29 |
| 1 Month Change | 13.51% |
| 3 Month Change | 23.53% |
| 1 Year Change | 2.88% |
| 3 Year Change | -10.19% |
| 5 Year Change | 7.18% |
| Change since IPO | 179.43% |
Recent News & Updates
Shareholder Returns
| 600789 | CN Pharmaceuticals | CN Market | |
|---|---|---|---|
| 7D | 18.4% | 5.7% | 4.2% |
| 1Y | 2.9% | -11.0% | -13.2% |
Return vs Industry: 600789 exceeded the CN Pharmaceuticals industry which returned -11% over the past year.
Return vs Market: 600789 exceeded the CN Market which returned -13.2% over the past year.
Price Volatility
| 600789 volatility | |
|---|---|
| 600789 Average Weekly Movement | 6.1% |
| Pharmaceuticals Industry Average Movement | 7.7% |
| Market Average Movement | 8.7% |
| 10% most volatile stocks in CN Market | 12.6% |
| 10% least volatile stocks in CN Market | 5.2% |
Stable Share Price: 600789's share price has been volatile over the past 3 months.
Volatility Over Time: 600789's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1966 | 6,484 | Kun Dong | www.lkpc.com |
Shandong Lukang Pharmaceutical Co.,Ltd. manufactures and sells bio-pharmaceuticals and antibiotics in China. The company offers human and animal active pharmaceutical ingredients; human and animal preparations; bio-pesticides; herbal medicines; and amino acid.
Shandong Lukang Pharmaceutical Co.,Ltd. Fundamentals Summary
| 600789 fundamental statistics | |
|---|---|
| Market cap | CN¥6.40b |
| Earnings (TTM) | CN¥267.79m |
| Revenue (TTM) | CN¥6.28b |
23.9x
P/E Ratio1.0x
P/S RatioIs 600789 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 600789 income statement (TTM) | |
|---|---|
| Revenue | CN¥6.28b |
| Cost of Revenue | CN¥4.79b |
| Gross Profit | CN¥1.48b |
| Other Expenses | CN¥1.21b |
| Earnings | CN¥267.79m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.30 |
| Gross Margin | 23.60% |
| Net Profit Margin | 4.27% |
| Debt/Equity Ratio | 74.2% |
How did 600789 perform over the long term?
See historical performance and comparison